Possible influence of variant of the P-glycoprotein gene (MDR1/ABCB1) on clinical response to guanfacine in children with pervasive developmental disorders and hyperactivity (Q33714538)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Possible influence of variant of the P-glycoprotein gene (MDR1/ABCB1) on clinical response to guanfacine in children with pervasive developmental disorders and hyperactivity	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Possible influence of variant of the P-glycoprotein gene (MDR1/ABCB1) on clinical response to guanfacine in children with pervasive developmental disorders and hyperactivity (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Lawrence Scahill

11

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Christopher J McDougle

3

object named as

Christopher J McDougle

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

L Eugene Arnold

7

object named as

L Eugene Arnold

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Benedetto Vitiello

10

object named as

Benedetto Vitiello

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

2

object named as

Michael G Aman

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

4

object named as

Elaine Tierney

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

8

object named as

David Posey

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

James T McCracken

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Sharon Shiraga

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Fiona Whelan

6

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Louise Ritz

9

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

1 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Journal of Child and Adolescent Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1-5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Impact of genetic polymorphisms of transporters on the pharmacokinetic, pharmacodynamic and toxicological properties of anionic drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835389

21 June 2018

Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835389

21 June 2018

The emerging importance of transporter proteins in the psychopharmacological treatment of the pregnant patient.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835389

21 June 2018

A "silent" polymorphism in the MDR1 gene changes substrate specificity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835389

21 June 2018

MDR1 genotype-related pharmacokinetics: fact or fiction?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835389

21 June 2018

Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835389

21 June 2018

Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835389

21 June 2018

Methylphenidate treatment in children with borderline IQ and mental retardation: analysis of three aggregated studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835389

21 June 2018

Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835389

21 June 2018

Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835389

21 June 2018

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835389

21 June 2018

Diagnosing autism: analyses of data from the Autism Diagnostic Interview.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835389

21 June 2018

The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835389

21 June 2018

Clonidine treatment of hyperactive and impulsive children with autistic disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835389

21 June 2018

Factor validity and norms for the aberrant behavior checklist in a community sample of children with mental retardation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835389

21 June 2018

Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835389

30 October 2018

A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835389

30 October 2018

A prospective open trial of guanfacine in children with pervasive developmental disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835389

30 October 2018

Behavioral and emotional problems in young people with pervasive developmental disorders: relative prevalence, effects of subject characteristics, and empirical classification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835389

30 October 2018

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835389

30 October 2018

Neuropsychiatric effects of guanfacine in children with mild tourette syndrome: a pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835389

30 October 2018

Factor analysis and norms for parent ratings on the Aberrant Behavior Checklist-Community for young people in special education.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835389

30 October 2018

A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835389

30 October 2018

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

1 reference

https://pubmed.ncbi.nlm.nih.gov/20166790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expert Consensus Guideline Series: Treatment of psychiatric and behavioral problems in mental retardation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20166790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1089/CAP.2009.0059

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33714538&oldid=2055117017"